PMDI

PSYCHEMEDICS CORP
—

Company Information

Company Name
PSYCHEMEDICS CORP
CIK
CIK0000806517
Category
Non-accelerated filer<br>Smaller reporting company
Ticker: Exchange
PMDI: OTC
Fiscal Year End
December 31
Owner Organization
08 Industrial Applications and Services
SIC
8071
SIC Description
Services-Medical Laboratories
Ticker
PMDI

SEC filing data through

Insider Sentiment

Last purchase
2024-12-17
Last sale
2024-12-10
Shares purchased (TTM)
1,504,412
Shares sold (TTM)
320,708
Buy ratio (TTM)82.4%

Institutional Sentiment

As of
2024-12-31
Institutional shares owned
296,561
Shares outstanding
5,867,000
Ownership
5.05%
-11.60% Y/Y

Earnings Market Reaction

Filing date
2025-03-24
Price on filing date
—
1-month reaction
4.52%
3-month reaction
0.00%
Drift continued6/12 (50%)
Faded / reversed6/12 (50%)

Balance Sheet

Values in millions ($)
Line item2024-12-312024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-31Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only columnTrend
Assets Current
Cash And Cash Equivalents At Carrying Value111121245322
Accounts Receivable Net Current333445444545
Prepaid Expense And Other Assets Current112112211221
Income Taxes Receivable000000000133
Assets Current56667881010111111
Property Plant And Equipment Net
Capitalized Computer Software Gross6---5---5---
Furniture And Fixtures Gross2---2---2---
Leasehold Improvements Gross4---4---4---
Property Plant And Equipment Gross242332734427566
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment-22222224-24232322-2202120
Property Plant And Equipment Net2---3---5---
Other Assets Noncurrent011111111111
Deferred Income Tax Assets Net----00111100
Operating Lease Right Of Use Asset111222233333
Finance Lease Right Of Use Asset00--0-------
Assets81010111214161819202021
Liabilities Current
Accounts Payable Current011111110111
Accrued Liabilities Current222233344433
Short Term Bank Loans And Notes Payable001-0-------
Long Term Debt Current000000000001
Finance Lease Liability Current00--0-------
Operating Lease Liability Current000111111111
Long Term Debt Noncurrent----00000001
Deferred Income Tax Liabilities Net-----0----0-
Liabilities Current344455666655
Operating Lease Liability Noncurrent011111122223
Finance Lease Liability Noncurrent00--0-------
Liabilities344567788999
Stockholders Equity
Preferred Stock Value00--0---0000
Common Stock Value000000000000
Additional Paid In Capital Common Stock353636353535353434343434
Treasury Stock Value-10-10-10-10-10-10-10-10-10-10-10-10
Retained Earnings Accumulated Deficit-19-19-18-17-17-16-14-13-12-11-10-10
Accumulated Other Comprehensive Income Loss Net Of Tax-2-2-2-2-2-2-2-2-2-2-2-2
Stockholders Equity55667791011121212
Liabilities And Stockholders Equity81010111214161819202021
Allowance For Doubtful Accounts Receivable Current000000000000
Preferred Stock Par Or Stated Value Per Share0.010.010.01-0.010.010.010.010.010.010.010.01
Preferred Stock Shares Authorized111-11111111
Preferred Stock Shares Issued000-00000000
Preferred Stock Shares Outstanding0-0-00000000
Common Stock Par Or Stated Value Per Share0.010.010.010.010.010.010.010.010.010.010.010.01
Common Stock Shares Authorized505050505050505050505050
Common Stock Shares Issued776666666666
Shares Outstanding666666666666
Treasury Stock Common Shares111111111---
Treasury Stock Shares--------1111

Select a line item above to chart it.

Recent filings

Financial statements beyond 3 years are for subscribers only.

Unlock 17+ years of income statements, balance sheets, and cash flow statements

Start 7-day free trial

PSYCHEMEDICS CORP (PMDI) — SEC Financial Statements & Analysis

PSYCHEMEDICS CORP (PMDI) is a services-medical laboratories company, incorporated in DE. PSYCHEMEDICS CORP trades on OTC as: PMDI. PSYCHEMEDICS CORP (PMDI)'s most recent SEC filing is a Form 10-K for the period ended 2024-12-31, filed with the SEC on 2025-03-24. Based on its latest SEC filing (Form 10-Q, period ending 2024-12-31), PSYCHEMEDICS CORP carries a market cap of $13.14M, a P/E ratio of -7.06x, a P/B ratio of 2.56x, a P/S ratio of 0.67x, an enterprise value of $11.81M, and an EV/EBITDA multiple of -6.24x. On profitability, it posts a gross margin of 36.07%, an operating margin of -9.62%, a net margin of -9.45%, a Return on Equity (ROE) of -31.54%, a Return on Assets (ROA) of -18.03%, and a Return on Invested Capital (ROIC) of -38.14%. Per share, it reports EPS of $-0.32, diluted EPS of $-0.32, free cash flow per share of $0.15, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of -10.92% year-over-year, net income growth of -55.20% year-over-year, and EPS growth of -56.17% year-over-year. On the balance sheet, it maintains a current ratio of 1.82x, a quick ratio of 1.45x, working capital of $2.23M, a debt-to-equity ratio of 0.62x, a debt ratio of 0.38, free cash flow of $878.00K (TTM), and net debt of $-1.34M. Figures sourced from SEC EDGAR.

Market Cap
$13.14M
P/E TTM
-7.06x
EPS TTM
$-0.32
P/B TTM
2.56x
ROE TTM
-31.54%
ROA TTM
-18.03%
Debt To Equity
0.62x
Free Cash Flow TTM
$878.00K
Net Revenue TTM Growth 1Y
-10.92%

Data as of 2024-12-31 · Source: SEC EDGAR

Frequently Asked Questions

What industry is PSYCHEMEDICS CORP in?

PSYCHEMEDICS CORP (PMDI) operates in the Services-Medical Laboratories industry.

What exchange does PMDI trade on?

PSYCHEMEDICS CORP (PMDI) trades on the OTC.

Where is PSYCHEMEDICS CORP incorporated?

PSYCHEMEDICS CORP is incorporated in DE.

When was PSYCHEMEDICS CORP (PMDI)'s most recent SEC filing?

PSYCHEMEDICS CORP (PMDI)'s most recent SEC filing is a Form 10-K for the period ended 2024-12-31, filed with the SEC on 2025-03-24.

What is PMDI's market cap?

PSYCHEMEDICS CORP (PMDI) has a market capitalization of $13.14M as of 2024-12-31.

What is PMDI's EPS (earnings per share)?

PSYCHEMEDICS CORP (PMDI)'s trailing twelve month EPS is $-0.32 as of 2024-12-31.

What is PMDI's ROE (return on equity)?

PSYCHEMEDICS CORP (PMDI)'s trailing twelve month Return on Equity (ROE) is -31.54% as of 2024-12-31.

What is PMDI's ROA (return on assets)?

PSYCHEMEDICS CORP (PMDI)'s trailing twelve month Return on Assets (ROA) is -18.03% as of 2024-12-31.

What is PMDI's ROIC (return on invested capital)?

PSYCHEMEDICS CORP (PMDI)'s trailing twelve month Return on Invested Capital (ROIC) is -38.14% as of 2024-12-31.

What is PMDI's EV/EBITDA?

PSYCHEMEDICS CORP (PMDI)'s trailing twelve month EV/EBITDA is -6.24x as of 2024-12-31.

Wall Street's data.
Main Street's price.